1. Home
  2. XLO vs FOXX Comparison

XLO vs FOXX Comparison

Compare XLO & FOXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XLO
  • FOXX
  • Stock Information
  • Founded
  • XLO 2016
  • FOXX 2017
  • Country
  • XLO United States
  • FOXX United States
  • Employees
  • XLO N/A
  • FOXX N/A
  • Industry
  • XLO Biotechnology: Pharmaceutical Preparations
  • FOXX
  • Sector
  • XLO Health Care
  • FOXX
  • Exchange
  • XLO Nasdaq
  • FOXX Nasdaq
  • Market Cap
  • XLO 35.7M
  • FOXX 37.7M
  • IPO Year
  • XLO 2021
  • FOXX N/A
  • Fundamental
  • Price
  • XLO $0.66
  • FOXX $6.24
  • Analyst Decision
  • XLO Buy
  • FOXX
  • Analyst Count
  • XLO 2
  • FOXX 0
  • Target Price
  • XLO $3.00
  • FOXX N/A
  • AVG Volume (30 Days)
  • XLO 341.9K
  • FOXX 17.8K
  • Earning Date
  • XLO 08-19-2025
  • FOXX 08-19-2025
  • Dividend Yield
  • XLO N/A
  • FOXX N/A
  • EPS Growth
  • XLO N/A
  • FOXX N/A
  • EPS
  • XLO N/A
  • FOXX N/A
  • Revenue
  • XLO $9,274,000.00
  • FOXX $53,866,257.00
  • Revenue This Year
  • XLO $300.08
  • FOXX N/A
  • Revenue Next Year
  • XLO $1.87
  • FOXX N/A
  • P/E Ratio
  • XLO N/A
  • FOXX N/A
  • Revenue Growth
  • XLO N/A
  • FOXX 3899.98
  • 52 Week Low
  • XLO $0.62
  • FOXX $2.45
  • 52 Week High
  • XLO $1.70
  • FOXX $12.80
  • Technical
  • Relative Strength Index (RSI)
  • XLO 42.53
  • FOXX N/A
  • Support Level
  • XLO $0.62
  • FOXX N/A
  • Resistance Level
  • XLO $0.70
  • FOXX N/A
  • Average True Range (ATR)
  • XLO 0.04
  • FOXX 0.00
  • MACD
  • XLO -0.00
  • FOXX 0.00
  • Stochastic Oscillator
  • XLO 46.15
  • FOXX 0.00

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

About FOXX Foxx Development Holdings Inc. Common Stock

Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals.

Share on Social Networks: